Detection, visualization and quantification of protein complexes in human Alzheimer's disease brains using proximity ligation assay

Sci Rep. 2023 Jul 24;13(1):11948. doi: 10.1038/s41598-023-38000-4.

Abstract

Examination of healthy and diseased human brain is essential to translational neuroscience. Protein-protein interactions play a pivotal role in physiological and pathological processes, but their detection is difficult, especially in aged and fixed human brain tissue. We used the in-situ proximity ligation assay (PLA) to broaden the range of molecular interactions assessable in-situ in the human neuropathology. We adapted fluorescent in-situ PLA to detect ubiquitin-modified proteins in human brains with Alzheimer's disease (AD), including approaches for the management of autofluorescence and quantification using a high-content image analysis system. We confirmed that phosphorylated microtubule-associated protein tau (Serine202, Threonine205) aggregates were modified by ubiquitin and that phospho-tau-ubiquitin complexes were increased in hippocampal and frontal cortex regions in AD compared to non-AD brains. Overall, we refined PLA for use in human neuropathology, which has revealed a profound change in the distribution of ubiquitin in AD brain and its association with characteristic tau pathologies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Alzheimer Disease* / metabolism
  • Brain / metabolism
  • Cerebral Cortex / metabolism
  • Humans
  • Ubiquitin / metabolism
  • Ubiquitinated Proteins / metabolism
  • tau Proteins / metabolism

Substances

  • tau Proteins
  • Ubiquitin
  • Ubiquitinated Proteins